Annora Pharma Private Ltd
General
Total Cases27
Active Cases10
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L4
E
PTAB
L2
B
CAFC
L2
B
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 11/22/24 | Letter from Charles H. Chevalier, Esq. to the Honorable Jose R. Almonte, U.S.M.J. re [141] Order, Terminate Motions. (CHEVALIER, CHARLES) (Entered: 11/22/2024) | |
| 11/22/24 | TEXT ORDER: The Defendants' request to defer findings on indefiniteness [ECF 51 & 145] is denied. Parties shall proceed with the discovery related to indefiniteness as ordered at ECF 141 & 147.So Ordered by Judge Michael E. Farbiarz on 11/22/2024. (ro, ) (Entered: 11/22/2024) | |
| 11/22/24 | TEXT ORDER: The appeal [ECF 116] is denied. The decision of United States Magistrate Judge Almonte [ECF 107] is affirmed for the reasons set out during oral argument on November 22, 2024.So Ordered by Judge Michael E. Farbiarz on 11/22/2024. (ro, ) (Entered: 11/22/2024) | |
| 11/22/24 | Minute Entry for proceedings held before Judge Michael E. Farbiarz: Motion Hearing held on 11/22/2024 re [116] APPEAL OF MAGISTRATE JUDGE DECISION to District Court by CATALYST PHARMACEUTICALS, INC., SERB SA re [107] Order filed by CATALYST PHARMACEUTICALS, INC., SERB SA. (Court Reporter, Lisa Larsen (973-776-7741)) (ro, ) (Entered: 11/22/2024) | |
| 11/21/24 | PROPOSED CONSENT JUDGMENT by Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/21/2024) | |
| 11/20/24 | TEXT ORDER: The Court is in receipt of the parties' letter (ECF No. [146] ) with their positions regarding the scheduling of additional Markman expert discovery. The parties shall proceed with discovery as follows: Expert depositions related to Markman shall be completed by December 13, 2024. Supplemental claim construction briefs shall be due by December 23, 2024. So Ordered by Magistrate Judge Jose R. Almonte on 11/19/2024. (akw, ) (Entered: 11/20/2024) | |
| 11/15/24 | SO ORDERED, re [150] Stipulation and Order to Extend Post-Trial Briefing. (*Resetting Post Trial Briefing Schedule: Proposed Findings of Fact and Conclusions of Law due 11/21/2024; Responsive Filings due 12/6/2024). Signed by Judge Jennifer L. Hall on 11/15/2024. (ceg) (Entered: 11/15/2024) | |
| 11/15/24 | Letter from Charles H. Chevalier to The Honorable Jose R. Almonte, U.S.M.J. (CHEVALIER, CHARLES) (Entered: 11/15/2024) | |
| 11/14/24 | Letter from Charles H. Chevalier, Esq. to The Honorable Michael E. Farbiarz, U.S.D.J.. (CHEVALIER, CHARLES) (Entered: 11/14/2024) | |
| 11/13/24 | STIPULATION TO EXTEND TIME of Post-Trial Briefing to Nov. 21, 2024 (Proposed Findings of Facts and Conclusions of Law) & Dec. 6, 2024 (Responses to Proposed Findings of Facts and Conclusions of Law) - filed by Pierre Fabre Pharmaceuticals, Inc., Pierre Fabre Medicament SAS, Universite de Bordeaux, Centre Hospitalier Universitaire de Bordeaux. (Simmons, John) (Entered: 11/13/2024) |